CanSino Biologics

About:

CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use.

Website: https://www.cansinotech.com.cn/

Top Investors: Bill & Melinda Gates Foundation

Description:

CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use. These vaccine products include pneumococcal polysaccharide and conjugate vaccines, and a DTcP-based combo, and other items. It is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine.